Related Experiment Video
Updated: Jun 17, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
Regulatory T Lymphocyte-Derived Extracellular Vesicles Play A Role in Chronic Kidney Diseases and Kidney
Reza Hajiasghar-Sharbaf1, Esmaeil Atashbasteh2, Hamed Fouladseresht1
1Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Regulatory T lymphocyte-derived extracellular vesicles (Treg-EVs) show promise in managing chronic kidney disease (CKD) and improving kidney transplant outcomes by modulating immune responses and potentially serving as diagnostic biomarkers.
Area of Science:
- Immunology
- Nephrology
- Cell Biology
Background:
- Chronic kidney disease (CKD) is a global health concern with high morbidity and mortality rates.
- Regulatory T lymphocytes (Tregs) are crucial for immune regulation, particularly in transplantation and autoimmune diseases.
- Treg-derived extracellular vesicles (Treg-EVs) are increasingly recognized for their immunomodulatory functions.
Purpose of the Study:
- To investigate the role of Treg-derived EVs in the pathogenesis of CKD.
- To explore the potential of Treg-EVs in promoting graft tolerance in kidney transplantation.
- To assess Treg-EVs as potential biomarkers for CKD diagnosis.
Main Methods:
- Analysis of Treg-EVs' effects on effector T lymphocytes (T effect) and cytokine production.
- Evaluation of Treg-EVs' capacity to induce apoptosis in immune cells.
- Investigation of Treg-EVs' correlation with CKD progression and transplant outcomes.
Main Results:
- Treg-EVs demonstrated the ability to suppress T effect cells and modulate cytokine profiles.
- Treg-EVs were shown to induce apoptosis, contributing to immune balance.
- Preliminary findings suggest Treg-EVs may serve as valuable biomarkers for CKD diagnosis.
Conclusions:
- Treg-derived EVs possess significant immunomodulatory properties relevant to CKD and kidney transplantation.
- Treg-EVs offer a promising avenue for novel diagnostic and therapeutic strategies in nephrology.
- Further research into Treg-EVs could revolutionize the management of kidney diseases and transplant rejection.
Abstract:
Chronic kidney disease (CKD) significantly affects kidney function, often leading to end-stage kidney disease (ESKD). Due to its high rates of morbidity, mortality, and economic effects, CKD is becoming the ninth most important risk factor for mortality worldwide, presenting serious healthcare issues. Regulatory T lymphocytes (Tregs) play a role in regulation, particularly in transplant tolerance and autoimmune conditions. Recent research has highlighted the potential of Tregderived vehicles (EVs) to modulate responses and promote graft tolerance during kidney transplantation. These EVs can suppress effector T lymphocytes (T effect), trigger apoptosis, and modify cytokine production to maintain balance and prevent graft rejection. Moreover, Treg-EVs have emerged as potential biomarkers for diagnosing CKD, paving the way for new diagnostic and therapeutic strategies. This study explores how Treg-derived EVs influence processes underlying CKD and kidney transplantation, highlighting their significance as useful tools.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...